ANNOUNCES COMPLETION OF ACQUISITION OF UNIVERSITY COMPOUNDING PHARMACY IN NORTH AMERICA
ACQUISITION VALUED AT $41.5 MILLION WITH $25 MILLION ANNUAL REVENUES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.